2024-05-03 |
2024-05-02 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
1,000
-100.0%
21.02
100,000
USD
|
1,000
-100.0%
|
21.02
|
100,000
USD
|
|
2024-05-03 |
2024-05-02 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
1,000
-100.0%
21.02
100,000
USD
|
1,000
-100.0%
|
21.02
|
100,000
USD
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,000
-100.0%
19.91
100,000
USD
|
1,000
-100.0%
|
19.91
|
100,000
USD
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,000
-100.0%
20.87
100,000
USD
|
1,000
-100.0%
|
20.87
|
100,000
USD
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,000
-90.3%
20.34
100,000
USD
|
1,000
-90.3%
|
20.34
|
100,000
USD
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
311
-8.7%
23.33
7,255
USD
|
311
-8.7%
|
23.33
|
7,255
USD
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
3,689
-50.9%
22.30
82,267
USD
|
3,689
-50.9%
|
22.30
|
82,267
USD
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
68
-5.0%
23.97
1,630
USD
|
68
-5.0%
|
23.97
|
1,630
USD
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
338
-19.9%
23.17
7,831
USD
|
338
-19.9%
|
23.17
|
7,831
USD
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
6,447
-79.2%
22.32
143,865
USD
|
6,447
-79.2%
|
22.32
|
143,865
USD
|
|
2024-04-18 |
2024-04-16 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
5,509
-100.0%
24.94
137,410
USD
|
5,509
-100.0%
|
24.94
|
137,410
USD
|
|
2024-04-18 |
2024-04-16 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
4,491
-44.9%
24.40
109,561
USD
|
4,491
-44.9%
|
24.40
|
109,561
USD
|
|
2024-04-12 |
2024-04-10 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
771
-28.2%
27.56
21,252
USD
|
771
-28.2%
|
27.56
|
21,252
USD
|
|
2024-04-12 |
2024-04-10 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
6,729
-71.1%
26.77
180,139
USD
|
6,729
-71.1%
|
26.77
|
180,139
USD
|
|
2024-04-11 |
2024-04-09 |
S
Sale
|
GRAYZEL DAVID S.
Non-Executive Director
|
11,882
-45.0%
28.15
334,478
USD
|
11,882
-45.0%
|
28.15
|
334,478
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,000
-100.0%
31.95
31,950
USD
|
1,000
-100.0%
|
31.95
|
31,950
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
2,851
-74.0%
31.02
88,446
USD
|
2,851
-74.0%
|
31.02
|
88,446
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,647
-30.0%
29.90
49,238
USD
|
1,647
-30.0%
|
29.90
|
49,238
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
4,502
-45.0%
28.96
130,399
USD
|
4,502
-45.0%
|
28.96
|
130,399
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
1,504
-100.0%
30.00
45,118
USD
|
1,504
-100.0%
|
30.00
|
45,118
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
3,796
-71.6%
28.87
109,579
USD
|
3,796
-71.6%
|
28.87
|
109,579
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
3,325
-72.0%
31.97
106,317
USD
|
3,325
-72.0%
|
31.97
|
106,317
USD
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
12,495
-86.4%
31.23
390,208
USD
|
12,495
-86.4%
|
31.23
|
390,208
USD
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
9,000
-73.5%
29.50
265,500
USD
|
9,000
-73.5%
|
29.50
|
265,500
USD
|
|
2024-03-28 |
2024-03-27 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
11,068
-89.6%
27.97
309,519
USD
|
11,068
-89.6%
|
27.97
|
309,519
USD
|
|
2024-03-27 |
2024-03-25 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
3,432
-72.7%
28.01
96,119
USD
|
3,432
-72.7%
|
28.01
|
96,119
USD
|
|
2024-03-20 |
2024-03-19 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
2,764
-100.0%
26.46
73,124
USD
|
2,764
-100.0%
|
26.46
|
73,124
USD
|
|
2024-03-20 |
2024-03-19 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNICAL OFFICER
Officer
|
2,536
-47.8%
25.68
65,119
USD
|
2,536
-47.8%
|
25.68
|
65,119
USD
|
|
2024-03-20 |
2024-03-18 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
7,581
-85.4%
26.48
200,764
USD
|
7,581
-85.4%
|
26.48
|
200,764
USD
|
|
2024-03-20 |
2024-03-18 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
27,476
-75.6%
25.74
707,282
USD
|
27,476
-75.6%
|
25.74
|
707,282
USD
|
|
2024-03-20 |
2024-03-18 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
613
-15.9%
26.40
16,185
USD
|
613
-15.9%
|
26.40
|
16,185
USD
|
|
2024-03-20 |
2024-03-18 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
6,387
-62.3%
25.81
164,872
USD
|
6,387
-62.3%
|
25.81
|
164,872
USD
|
|
2024-03-14 |
2024-03-13 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
2,016
-50.7%
25.02
50,445
USD
|
2,016
-50.7%
|
25.02
|
50,445
USD
|
|
2024-03-14 |
2024-03-12 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
2,051
-51.1%
25.05
51,370
USD
|
2,051
-51.1%
|
25.05
|
51,370
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
10
-0.5%
26.31
263
USD
|
10
-0.5%
|
26.31
|
263
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
3,423
-63.5%
25.24
86,404
USD
|
3,423
-63.5%
|
25.24
|
86,404
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
114
-5.5%
25.00
2,850
USD
|
114
-5.5%
|
25.00
|
2,850
USD
|
|
2024-03-11 |
2024-03-07 |
PS
Planned sale
|
Eldridge George A
SEE REMARKS
Officer
|
22,386
-91.9%
25.00
559,688
USD
|
22,386
-91.9%
|
25.00
|
559,688
USD
|
|
2024-03-11 |
2024-03-07 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
8,975
-73.4%
24.50
219,888
USD
|
8,975
-73.4%
|
24.50
|
219,888
USD
|
|
2024-02-27 |
2024-02-23 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
511
-13.6%
19.50
9,965
USD
|
511
-13.6%
|
19.50
|
9,965
USD
|
|
2024-02-22 |
2024-02-20 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
898
-21.6%
20.58
18,478
USD
|
898
-21.6%
|
20.58
|
18,478
USD
|
|
2024-02-22 |
2024-02-20 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
2,591
-38.4%
20.11
52,097
USD
|
2,591
-38.4%
|
20.11
|
52,097
USD
|
|
2024-02-07 |
2024-02-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
4,600
-74.1%
17.45
80,249
USD
|
4,600
-74.1%
|
17.45
|
80,249
USD
|
|
2024-01-19 |
2024-01-17 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
4,000
-55.2%
19.50
78,000
USD
|
4,000
-55.2%
|
19.50
|
78,000
USD
|
|
2024-01-08 |
2024-01-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
2,474
-60.6%
19.57
48,421
USD
|
2,474
-60.6%
|
19.57
|
48,421
USD
|
|
2024-01-08 |
2024-01-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
2,126
-34.2%
18.67
39,695
USD
|
2,126
-34.2%
|
18.67
|
39,695
USD
|
|
2023-12-29 |
2023-12-27 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
125
-3.7%
24.50
3,063
USD
|
125
-3.7%
|
24.50
|
3,063
USD
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
4,000
-55.2%
19.50
78,000
USD
|
4,000
-55.2%
|
19.50
|
78,000
USD
|
|
2023-12-15 |
2023-12-14 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
9,897
-75.3%
19.50
192,992
USD
|
9,897
-75.3%
|
19.50
|
192,992
USD
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
2,103
-39.3%
19.50
41,009
USD
|
2,103
-39.3%
|
19.50
|
41,009
USD
|
|
2023-12-07 |
2023-12-06 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
10,283
-88.8%
16.11
165,628
USD
|
10,283
-88.8%
|
16.11
|
165,628
USD
|
|
2023-12-07 |
2023-12-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
4,600
-74.1%
16.30
74,996
USD
|
4,600
-74.1%
|
16.30
|
74,996
USD
|
|
2023-11-29 |
2023-11-27 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
12,517
-90.7%
16.24
203,237
USD
|
12,517
-90.7%
|
16.24
|
203,237
USD
|
|
2023-11-27 |
2023-11-24 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
70
-5.1%
16.07
1,125
USD
|
70
-5.1%
|
16.07
|
1,125
USD
|
|
2023-11-27 |
2023-11-24 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
4,920
-78.3%
15.74
77,423
USD
|
4,920
-78.3%
|
15.74
|
77,423
USD
|
|
2023-11-27 |
2023-11-22 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
13,800
-89.6%
15.00
207,000
USD
|
13,800
-89.6%
|
15.00
|
207,000
USD
|
|
2023-11-27 |
2023-11-22 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
9,382
-87.9%
15.17
142,359
USD
|
9,382
-87.9%
|
15.17
|
142,359
USD
|
|
2023-11-03 |
2023-11-01 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
1,092
-100.0%
10.42
11,379
USD
|
1,092
-100.0%
|
10.42
|
11,379
USD
|
|
2023-11-03 |
2023-11-01 |
PS
Planned sale
|
Verwijs Marinus
CHIEF TECHNOLOGY OFFICER
Officer
|
970
-100.0%
10.46
10,149
USD
|
970
-100.0%
|
10.46
|
10,149
USD
|
|
2023-09-08 |
2023-09-07 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
30
-2.3%
15.01
450
USD
|
30
-2.3%
|
15.01
|
450
USD
|
|
2023-09-08 |
2023-09-06 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
3,931
-75.3%
15.06
59,187
USD
|
3,931
-75.3%
|
15.06
|
59,187
USD
|
|
2023-08-09 |
2023-08-07 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
541
-29.5%
16.25
8,789
USD
|
541
-29.5%
|
16.25
|
8,789
USD
|
|
2023-08-09 |
2023-08-07 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
9,742
-84.2%
15.48
150,792
USD
|
9,742
-84.2%
|
15.48
|
150,792
USD
|
|
2023-08-01 |
2023-07-28 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
5,478
-100.0%
18.00
98,604
USD
|
5,478
-100.0%
|
18.00
|
98,604
USD
|
|
2023-07-19 |
2023-07-17 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
4,522
-100.0%
18.11
81,896
USD
|
4,522
-100.0%
|
18.11
|
81,896
USD
|
|
2023-07-07 |
2023-07-06 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
10,283
-88.8%
16.66
171,284
USD
|
10,283
-88.8%
|
16.66
|
171,284
USD
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
219
-12.0%
17.87
3,913
USD
|
219
-12.0%
|
17.87
|
3,913
USD
|
|
2023-07-07 |
2023-07-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
2,031
-52.6%
17.23
35,002
USD
|
2,031
-52.6%
|
17.23
|
35,002
USD
|
|
2023-07-05 |
2023-07-03 |
PS
Planned sale
|
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER
Executive Director
|
10,000
-100.0%
18.00
180,000
USD
|
10,000
-100.0%
|
18.00
|
180,000
USD
|
|
2023-06-08 |
2023-06-06 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
15
-1.1%
16.98
255
USD
|
15
-1.1%
|
16.98
|
255
USD
|
|
2023-06-08 |
2023-06-06 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
10,268
-88.7%
16.28
167,161
USD
|
10,268
-88.7%
|
16.28
|
167,161
USD
|
|
2023-06-07 |
2023-06-05 |
PS
Planned sale
|
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER
Officer
|
2,250
-58.3%
16.26
36,576
USD
|
2,250
-58.3%
|
16.26
|
36,576
USD
|
|
2023-05-23 |
2023-05-19 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
65
-2.0%
19.50
1,268
USD
|
65
-2.0%
|
19.50
|
1,268
USD
|
|
2023-05-19 |
2023-05-17 |
PS
Planned sale
|
Gillies Hunter
CHIEF MEDICAL OFFICER
Officer
|
1,090
-25.1%
19.59
21,356
USD
|
1,090
-25.1%
|
19.59
|
21,356
USD
|
|
2023-05-09 |
2023-05-08 |
PS
Planned sale
|
Dake Benjamin T
SEE REMARKS
Officer
|
1,599
-55.3%
22.74
36,355
USD
|
1,599
-55.3%
|
22.74
|
36,355
USD
|
|